📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Inclusion of pregnant women in COVID-19 vaccine development. (2020)

First Author: Heath PT

Attributed to: MICA:The immunogenicity of combined pertussis-containing vaccine (Tdap) for HIV-infected pregnant women and their newborns-A Randomized Clinical Trial funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(20)30638-1

PubMed Identifier: 32795409

Publication URI: http://europepmc.org/abstract/MED/32795409

Type: Journal Article/Review

Volume: 20

Parent Publication: The Lancet. Infectious diseases

Issue: 9

ISSN: 1473-3099